Eye-trackers: Novel Technology for Concussions and Brain Health Research

Talk Polymath Ep. 6 | Eye-trackers: Novel Technology for Concussions & Brain Health Research

TICKETS

https://www.eventbrite.com/e/eye-trackers-novel-technology-for-concussions-and-brain-health-research-tickets-161125575935?aff=eand

DETAILS

This episode of Talk Polymath discusses novel technologies for brain health and how eye movement can be used to diagnose and treat concussions. The guests will share the science behind their concussion diagnostic tool, the data that drives it, and how they see the future of brain health. Our guests are Rosina Samadani, Ph.D., CEO of Oculogica, and Dr. Uzma Samadani, M.D., Ph.D., Founder of Oculogica, Associate Professor, Department of Bioinformatics and Computational Biology at the University of Minnesota, and attending neurosurgeon at the Minneapolis Veterans Administration Medical Center.

—–

Dr. Rosina Samadani has 20 years of experience with medical device companies, including 7 years with McKinsey & Company as a leader in their healthcare practice. This is her 4th startup. Dr. Samadani has her BS and MS from MIT in Mechanical Engineering, and her Ph.D. in Biomedical Engineering from Northwestern University.

Dr. Uzma Samadani founded Oculogica in 2013, and her laboratory has developed the eye-tracking methodology and published six papers on its utility. She is currently an Associate Professor in the Department of Bioinformatics and Computational Biology at the University of Minnesota with a graduate faculty appointment in Neuroscience. She is also an attending neurosurgeon at the Minneapolis Veterans Administration Medical Center. She serves on the Executive Committee of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Section on Neurotrauma and Critical Care.

—–

Come join us and bring your questions!

For more information and schedules visit polyplexus.com.

The event is finished.

Date

Jun 30 2021
Expired!

Time

7:00 pm - 8:00 pm

Leave A Reply

Your email address will not be published.